Dr. Rosenbluth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Barnes Jewish Hospital Plz
Saint Louis, MO 63110Phone+1 314-362-7578Fax+1 314-286-1021- Is this information wrong?
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 1992 - 1995
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1989 - 1992
- Icahn School of Medicine at Mount SinaiClass of 1989
Certifications & Licensure
- IL State Medical License 1991 - 2026
- MO State Medical License 1994 - 2025
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion Start of enrollment: 2014 Mar 01
- Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF) Start of enrollment: 2014 Aug 01
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Start of enrollment: 2015 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsRiociguat for the treatment of Phe508del homozygous adults with cystic fibrosis.Nico Derichs, Jennifer L. Taylor-Cousar, Jane C. Davies, Isabelle Fajac, Elizabeth Tullis, Dilip Nazareth, Damian G. Downey, Daniel B. Rosenbluth, Anne Malfroot, Clare...> ;Journal of Cystic Fibrosis. 2021 Aug 19
- 31 citationsEvaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design.Nicole Mayer-Hamblett, David P. Nichols, Katherine Odem-Davis, Kristin A. Riekert, Greg S. Sawicki, Scott H. Donaldson, Felix Ratjen, Michael W. Konstan, Noah Simon, D...> ;Annals of the American Thoracic Society. 2021 Jul 30
- 10 citationsThe impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network.K. Pearson, Nicole Mayer-Hamblett, Christopher H. Goss, George Z. Retsch-Bogart, Jill M. VanDalfsen, Patricia Burks, Daniel B. Rosenbluth, John P. Clancy, Amy Hoffman,...> ;Journal of Cystic Fibrosis. 2021 Mar 1
- Join now to see all
Press Mentions
- List of Temporary Practice Permits Granted May 5, 2020May 5th, 2020
- New Drug Appears to Slow Effects of Cystic Fibrosis, Offering Hope to Long-Suffering PatientsDecember 18th, 2019
Hospital Affiliations
- Barnes-Jewish HospitalSaint Louis, Missouri
- Barnes-Jewish West County HospitalSaint Louis, Missouri
- Siteman Cancer CenterSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: